M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.37 USD 0.85% Market Closed
Market Cap: 117.3m USD
Have any thoughts about
MDxHealth SA?
Write Note

Relative Value

The Relative Value of one MDXH stock under the Base Case scenario is 9.06 USD. Compared to the current market price of 2.37 USD, MDxHealth SA is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXH Relative Value
Base Case
9.06 USD
Undervaluation 74%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
89
Median 3Y
2.4
Median 5Y
23.2
Industry
7.5
Forward
1.3
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-8.8
Industry
21.6
Forward
-1.9
vs History
vs Industry
22
Median 3Y
7
Median 5Y
11
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
N/A

Multiples Across Competitors

MDXH Competitors Multiples
MDxHealth SA Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
BE
MDxHealth SA
NASDAQ:MDXH
117.3m USD 1 -2 -13.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 095 167.8 -181 060.7 -186 254.1
US
Abbvie Inc
NYSE:ABBV
314B USD 5.7 61.8 52.1
US
Amgen Inc
NASDAQ:AMGN
140.1B USD 4.3 33.1 18.6
US
Gilead Sciences Inc
NASDAQ:GILD
115.1B USD 4.1 913.4 6.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.8B USD 9.8 -216.3 6.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.3 -471.9 -4 833.5
AU
CSL Ltd
ASX:CSL
136.1B AUD 5.7 31.9 4.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 5.7 16.8 2.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 16.1
NL
argenx SE
XBRU:ARGX
35.9B EUR 17.1 -330.9 8.8
P/S Multiple
Revenue Growth P/S to Growth
BE
M
MDxHealth SA
NASDAQ:MDXH
Average P/S: 3 463 371.6
1
20%
0
FR
Pharnext SCA
OTC:PNEXF
38 095 167.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
6%
0.9
US
Amgen Inc
NASDAQ:AMGN
4.3
8%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
4.1
3%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.8
10%
1
US
E
Epizyme Inc
F:EPE
1 849.3
N/A N/A
AU
CSL Ltd
ASX:CSL
5.7
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.7
7%
0.8
US
S
Seagen Inc
F:SGT
17.8
30%
0.6
NL
argenx SE
XBRU:ARGX
17.1
47%
0.4
P/E Multiple
Earnings Growth PEG
BE
M
MDxHealth SA
NASDAQ:MDXH
Average P/E: 211.4
Negative Multiple: -2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 060.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
61.8
72%
0.9
US
Amgen Inc
NASDAQ:AMGN
33.1
20%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
913.4
21%
43.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -216.3
14%
N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -471.9 N/A N/A
AU
CSL Ltd
ASX:CSL
31.9
18%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.8
13%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -330.9 N/A N/A